Company Filing History:
Years Active: 2017
Title: Doreen Claussnitzer: Pioneering Innovations in Recombinant Protein Production
Introduction
Doreen Claussnitzer, based in Munich, Germany, is an accomplished inventor with a focus on biotechnological advancements. Her notable work has led to a significant patent that aims to improve the production of recombinant proteins, a critical component in various medical and industrial applications.
Latest Patents
Doreen holds a patent titled “Method for increasing the secretion of recombinant proteins.” This invention details a method for producing recombinant protein in cells featuring a cell wall. The process involves enhancing the secretion of the protein across the cell wall by expressing it in a culture medium that includes a specific combination of a surface-active polymer and monovalent metal ions, ensuring an osmolarity of at least 0.32 osmol/L. The patent also encompasses culture media and nutrient mixtures designed for this method, showcasing innovative approaches to biotechnology.
Career Highlights
Her professional journey includes her role at Greenovation Biotech GmbH, where she applies her expertise in biotechnology to drive innovations forward. Doreen's work not only contributes to her company's goals but also enhances the research landscape for recombinant protein production, fostering advancements that could benefit numerous sectors including healthcare and pharmaceuticals.
Collaborations
Doreen collaborates closely with her colleagues Wolfgang Jost and Mathias Knappenberger, leveraging their collective knowledge and skills to further refine and develop innovative biotechnological solutions. Their joint efforts exemplify the collaborative spirit within the biotechnological field, contributing to shared goals and breakthroughs.
Conclusion
Doreen Claussnitzer stands as a leading figure in the realm of recombinant protein research and production. Her patented invention reflects significant advancements in biotechnology, setting the groundwork for future innovations. With a strong emphasis on collaboration and applied research, Doreen continues to drive progress in this vital field.